a FDA set to decide on two likely blockbuster drugs by Sanofi Genzyme

... d division of Sanofi (NYSE: SNY) that's focused on specialty pharmaceuticals (formerly called simply Genzyme), and Tarrytown, N.Y.-based Regeneron Pharmaceuticals...
http://ift.tt/2dvScFr